V013-2247 Screening compound: N-[2-(MORPHOLIN-4-YL)ETHYL]-2-[3-(TRIFLUOROMETHYL)BENZAMIDO]-1,3-THIAZOLE-4-CARBOXAMIDE

V013-2247 Screening compound: N-[2-(MORPHOLIN-4-YL)ETHYL]-2-[3-(TRIFLUOROMETHYL)BENZAMIDO]-1,3-THIAZOLE-4-CARBOXAMIDE
V013-2247 Screening compound: N-[2-(MORPHOLIN-4-YL)ETHYL]-2-[3-(TRIFLUOROMETHYL)BENZAMIDO]-1,3-THIAZOLE-4-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound V013-2247
N-[2-(MORPHOLIN-4-YL)ETHYL]-2-[3-(TRIFLUOROMETHYL)BENZAMIDO]-1,3-THIAZOLE-4-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V013-2247

Molecular Formula

C18H19F3N4O3S (C18 H19 F3 N4 O3 S)

Compound Name

N-[2-(MORPHOLIN-4-YL)ETHYL]-2-[3-(TRIFLUOROMETHYL)BENZAMIDO]-1,3-THIAZOLE-4-CARBOXAMIDE

IUPAC name

n/a

SMILES

O=C(c1csc(NC(c2cc(C(F)(F)F)ccc2)=O)n1)NCCN1CCOCC1

InChI

InChI=1S/C18H19F3N4O3S/c19-18(20,21)13-3-1-2-12(10-13)15(26)24-17-23-14(11-29-17)16(27)22-4-5-25-6-8-28-9-7-25/h1-3,10-11H,4-9H2,(H,22,27)(H,23,24,26)

InChI Key

SFKQMKADFMDAPU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19976049

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

428.44

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.467

Distribution Coefficient, logD

1.946

Water Solubility, LogSw

-3.02

Polar Surface Area

69.522

Acid Dissociation Constant (pKa)

7.03

Base Dissociation Constant (pKb)

6.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.90

V013-2247 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

PI3K-Targeted Library (17255 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with V013-2247 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V013-2247?
Check Price and Availability of V013-2247, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V013-2247 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V013-2247
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V013-2247
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V013-2247 available by request